Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$665,637,338
-$172,548,644 QoQ
Shares Held
2,620,929
-23.6% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#82
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $5,636,745,309 across 13 Drug Manufacturers - General names. JNJ ranks #2 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,141,447 | $2,568,515,989 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,620,929 | $665,637,338 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
10,168,924 | $585,933,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,143,885 | $532,489,222 | |
| 5 | ABBV |
AbbVie Inc.
|
1,581,740 | $398,029,053 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,203,012 | $278,328,536 | |
| 7 | AMGN |
Amgen Inc
|
632,302 | $228,969,200 | |
| 8 | PFE |
Pfizer Inc
|
9,152,541 | $220,393,187 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $665,637,338 | 2,620,929 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $838,185,982 | 3,429,005 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $870,097,682 | 4,204,386 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $851,941,486 | 4,594,658 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $644,133,764 | 4,216,915 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $480,366,173 | 2,896,564 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $359,167,674 | 2,483,527 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $431,158,685 | 2,660,488 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $379,465,269 | 2,596,232 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $468,844,629 | 2,963,807 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $353,448,229 | 2,254,997 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $363,781,537 | 2,335,676 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $425,224,024 | 2,569,019 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $412,219,245 | 2,659,479 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $502,397,369 | 2,844,027 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $479,377,469 | 2,934,485 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $551,184,880 | 3,105,092 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $542,886,328 | 3,063,174 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $480,960,225 | 2,811,482 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $441,688,288 | 2,734,912 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $425,741,371 | 2,584,323 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $394,428,659 | 2,399,931 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $386,501,515 | 2,455,849 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $408,520,020 | 2,743,955 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $363,547,394 | 2,585,134 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $361,538,523 | 2,757,100 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||